Answers are grounded in this paper and cite their sources.
It seems that targeting MMP-2 and VEGF-C may improve local control, thereby reducing the risk of distant metastasis in patients with SCC of the tongue and FOM.
No takes yet. Share an insight, caveat, or question.
Gontarz et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: